You searched for "AMM"

2004 results found

GREG: An Introduction to Diabetic Retinopathy Grading

Gloucestershire Research & Education Group An Introduction to Diabetic Retinopathy (DR) Grading

GREG (Gloucestershire Research & Education Group): Introduction to Grading Diabetic Retinopathy (DR)

This course has been designed to introduce students to grading in diabetic retinopathy, based around national standards. It consists of pre-course online learning, and two days of face to face training. It explores diabetic retinopathy in depth, and provides students with an extensive understanding of how this condition is classified. The teaching is provided by Gloucestershire Research & Education Group and participants will receive an in-house certificate from the Gloucestershire Research & Education Group, on successful completion.

AI in anterior segment disease - what you need to know! @ 100% Ophthalmology

@11:30 – 12:30 Everything you need to understand before you start to consider using AI in your practice with a focus on anterior segment disease!

Sight Sciences: Early Intervention with Implant-Free MIGS. The OMNI Surgical System

Agenda 18:30 Arrival & Refreshments19:00 Introductions & Welcome : Ms. Indira Madgula (Moderator), Royal Preston Hospital19:15 The Patients’ Perspective : Why MIGS, Why OMNI: Dr. Andrew Tatham, Princess Alexandra Eye Pavilion, Edinburgh19:45 Q&A - Discussion20:15 Close - Buffet Dinner

My Top Five: Promising gene therapies for ocular conditions

Gene therapy, a pivotal advancement in modern medicine, particularly shines in ophthalmology. By targeting defective genes with engineered vectors, this approach promises significant strides in treating inherited retinal diseases. This article reviews the top five gene therapies in late-stage trials,...

My Top Five: Promising gene therapies for ocular conditions

Gene therapy, a pivotal advancement in modern medicine, particularly shines in ophthalmology. By targeting defective genes with engineered vectors, this approach promises significant strides in treating inherited retinal diseases. This article reviews the top five gene therapies in late-stage trials,...

A day in the life of...an ophthalmic imager / an orthoptic assistant

The ophthalmic imager My role as an ophthalmic / medical photographer has evolved, dramatically, since I began my career at Manchester Royal Eye Hospital, 30 years ago. Long gone are the days of developing and hand printing fluorescein angiograms in...

Surgical treatment of high myopia

Although several excellent modalities are available for correcting high myopia, the surgical treatment of this condition remains one of the biggest challenges for refractive surgeons; this group of patients is often very dependent on contact lenses. If these patients become...

Last UKISCRS webinar of 2020 will be a festive celebration

The festive webinar will be held on Thursday 3 December at 7pm.

SpaMedica launches pre-reg training programme to support future generations of optometrists

SpaMedica is partnering with Vision Express to offer pre-registration training placements to 150 aspiring optometrists. Trainees will have the opportunity to shadow SpaMedica’s clinical teams and in-house optometrists as they treat patients with a variety of eye conditions, including cataracts...

Scottish universities transform eye health research with retinal imaging resource

Retinal imaging network achieves millionth image milestone in fight against diseases. A Scottish research initiative which set out to safeguard retinal images for innovation in eye research has reached a major milestone. Having secured over one million retinal images since...

RaScaL Study

The RaScaL study was a six month, single-centre, controlled, prospective phase I/II study in which subjects with diabetic macular oedema (DME) and associated peripheral nonperfusion on ultrawide-field fluorescein angiography (UWFA) were randomised to: (1) study arm: ranibizumab (0.5 mg) injection...